Evidence map›Paper›PMID 34863131›Full record

ArticleBMC psychiatry2021

Youth in transition: Study protocol of a prospective cohort study into the long-term course of addiction, mental health problems and social functioning in youth entering addiction treatment.

Christina Moska, Anna E Goudriaan, Peter Blanken, Dike van de Mheen, Renske Spijkerman, Arnt Schellekens, Jannet de Jonge, Floris Bary, Wilma Vollebergh, Vincent Hendriks

Abstract readClinical Trial Protocol
In one paragraph

Article in BMC psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Fatal overdose: Predicting to prevent.The International journal on drug policy · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Christina MoskaParnassia Addiction Research Centre (PARC, Brijder Addiction Treatment), Zoutkeetsingel 40, 2512 HN, The Hague, the Netherlands.
Anna E GoudriaanDepartment of Psychiatry, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands. a.e.goudriaan@amsterdamumc.nl.ORCID 0000-0001-8670-9384
Peter BlankenParnassia Addiction Research Centre (PARC, Brijder Addiction Treatment), Zoutkeetsingel 40, 2512 HN, The Hague, the Netherlands.
Dike van de MheenDepartment of Tranzo Scientific Center for Care and Wellbeing, Tilburg University, Tilburg, the Netherlands.
Renske SpijkermanParnassia Addiction Research Centre (PARC, Brijder Addiction Treatment), Zoutkeetsingel 40, 2512 HN, The Hague, the Netherlands.
Arnt SchellekensDepartment of Psychiatry, Radboud University Medical Centre, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands.
Jannet de JongeResearch Group Urban Vitality, Faculty of Health, Amsterdam University of Applied Science, Amsterdam, the Netherlands.
Floris BaryNetherlands Network of Client Councils in Addiction Care 'Het Zwarte Gat', Hollands Kroon, The Netherlands.
Wilma VolleberghDepartment of Interdisciplinary Social Science, Utrecht University, Utrecht, the Netherlands.
Vincent HendriksParnassia Addiction Research Centre (PARC, Brijder Addiction Treatment), Zoutkeetsingel 40, 2512 HN, The Hague, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSubstance use disorders (SUDs) are prevalent in the general population, tend to follow a chronic course, are associated with many individual and social problems, and often have their onset in adolescence. However, the knowledge base from prospective population surveys and treatment-outcome studies on the course of SUD in adolescents is limited at best. The present study aims to fill this gap and focuses on a subgroup that is particularly at risk for chronicity: adolescents in addiction treatment. We will investigate the rate of persistent SUD and its predictors longitudinally from adolescence to young adulthood among youth with DSM-5 SUD from the start of their addiction treatment to 2 and 4 years following treatment-entry. In addition to SUD, we will investigate the course of comorbid mental disorders, social functioning, and quality of life and their association with SUD over time. METHODS/

designIn a naturalistic, multi-center prospective cohort design, we will include youths (n = 420), who consecutively enter addiction treatment at ten participating organizations in the Netherlands. Inclusion is prestratified by treatment organization, to ensure a nationally representative sample. Eligible youths are 16 to 22 years old and seek help for a primary DSM-5 cannabis, alcohol, cocaine or amphetamine use disorder. Assessments focus on lifetime and current substance use and SUD, non-SUD mental disorders, family history, life events, social functioning, treatment history, quality of life, chronic stress indicators (hair cortisol) and neuropsychological tests (computerized executive function tasks) and are conducted at baseline, end of treatment, and 2 and 4 years post-baseline. Baseline data and treatment data (type, intensity, duration) will be used to predict outcome - persistence of or desistance from SUD. DISCUSSION: There are remarkably few prospective studies worldwide that investigated the course of SUD in adolescents in addiction treatment for longer than 1 year. We are confident that the Youth in Transition study will further our understanding of determinants and consequences of persistent SUD among high-risk adolescents during the critical transition from adolescence to young adulthood.

trial registrationThe Netherlands National Trial Register Trial NL7928 . Date of registration January 17, 2019.

Indexed as

Mental HealthSubstance-Related DisordersAdolescentAdultCohort StudiesHumansProspective StudiesQuality of LifeSocial InteractionYoung AdultAdolescentsLong-term course of SUDProspective cohort studySubstance use disorderYouth addiction treatment

Identifiers

PMID34863131
PMCPMC8642918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.